Predict your next investment

VIB company logo
Non-Profit Foundation
HEALTHCARE | Medical Facilities & Services / Medical Laboratories & Research
vib.be

See what CB Insights has to offer

Investments

17

Portfolio Exits

4

Partners & Customers

10

About VIB

VIB provides basic research in life sciences. VIB's technology transfer activities translate research results into new, economic ventures, which, in time, lead to new products that can be used in medicine, agriculture, and other applications. VIB also engages actively in the public debate on biotechnology by developing and disseminating a wide range of science-based information about all aspects of biotechnology.

VIB Headquarter Location

Rijvisschestraat 120

Ghent, 9052,

Belgium

+32 9 244 66 11

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

VIB Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

VIB Rank

VIB Investments

17 Investments

VIB has made 17 investments. Their latest investment was in Muna Therapeutics as part of their Series A on July 7, 2021.

CBI Logo

VIB Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

7/9/2021

Series A

Muna Therapeutics

$73M

Yes

12

4/8/2021

Series A

Protealis

$7.12M

Yes

2

3/16/2021

Series A - II

ExeVir Bio

$22.65M

No

1

11/30/2020

Series B

Subscribe to see more

$99M

Subscribe to see more

10

7/28/2020

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/9/2021

4/8/2021

3/16/2021

11/30/2020

7/28/2020

Round

Series A

Series A

Series A - II

Series B

Series A

Company

Muna Therapeutics

Protealis

ExeVir Bio

Subscribe to see more

Subscribe to see more

Amount

$73M

$7.12M

$22.65M

$99M

$99M

New?

Yes

Yes

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

12

2

1

10

10

VIB Portfolio Exits

4 Portfolio Exits

VIB has 4 portfolio exits. Their latest portfolio exit was Biotalys on July 01, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

7/1/2021

IPO

$99M

2

9/1/2017

Divestiture

Subscribe to see more

Subscribe to see more

10

12/20/2016

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

7/9/2014

IPO

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/1/2021

9/1/2017

12/20/2016

7/9/2014

Exit

IPO

Divestiture

Acquired

IPO

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

2

10

10

10

VIB Partners & Customers

10 Partners and customers

VIB has 10 strategic partners and customers. VIB recently partnered with Hedera-22 on January 1, 2022.

Date

Type

Business Partner

Country

News Snippet

Sources

1/10/2022

Partner

Belgium

12/22/2021

Partner

Netherlands

SkylineDx And VIB Enter A Strategic Partnership In Molecular Diagnostics

ROTTERDAM , Netherlands and SAN DIEGO and GHENT , Belgium , Dec. 22 , 2021 / PRNewswire / -- Today , SkylineDx announced a 3-year strategic partnership with life sciences institute VIB for the evaluation and initiation of collaborative projects focused on molecular diagnostics .

3

12/22/2021

Partner

Netherlands

SkylineDx and VIB Enter a Strategic Partnership in Molecular Diagnostics - CMOCRO

ROTTERDAM , Netherlands and SAN DIEGO and GHENT , Belgium , Dec. 22 , 2021 / PRNewswire / -- Today , SkylineDx announced a 3-year strategic partnership with life sciences institute VIB for the evaluation and initiation of collaborative projects focused on molecular diagnostics .

1

12/22/2021

Partner

Netherlands

Subscribe to see more

Subscribe to see more

10

5/6/2021

Licensee

United States

Subscribe to see more

Subscribe to see more

10

Date

1/10/2022

12/22/2021

12/22/2021

12/22/2021

5/6/2021

Type

Partner

Partner

Partner

Partner

Licensee

Business Partner

Country

Belgium

Netherlands

Netherlands

Netherlands

United States

News Snippet

SkylineDx And VIB Enter A Strategic Partnership In Molecular Diagnostics

ROTTERDAM , Netherlands and SAN DIEGO and GHENT , Belgium , Dec. 22 , 2021 / PRNewswire / -- Today , SkylineDx announced a 3-year strategic partnership with life sciences institute VIB for the evaluation and initiation of collaborative projects focused on molecular diagnostics .

SkylineDx and VIB Enter a Strategic Partnership in Molecular Diagnostics - CMOCRO

ROTTERDAM , Netherlands and SAN DIEGO and GHENT , Belgium , Dec. 22 , 2021 / PRNewswire / -- Today , SkylineDx announced a 3-year strategic partnership with life sciences institute VIB for the evaluation and initiation of collaborative projects focused on molecular diagnostics .

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

3

1

10

10

VIB Team

5 Team Members

VIB has 5 team members, including current Chief Financial Officer, Rik Audenaert.

Name

Work History

Title

Status

Rik Audenaert

Chief Financial Officer

Current

Wim Goemaere

Chief Operating Officer

Current

Johan Cardoen

Managing Director

Former

Rudy Dekeyser

Managing Director

Former

beth coulter

Owner

Former

Name

Rik Audenaert

Wim Goemaere

Johan Cardoen

Rudy Dekeyser

beth coulter

Work History

Title

Chief Financial Officer

Chief Operating Officer

Managing Director

Managing Director

Owner

Status

Current

Current

Former

Former

Former

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.